Versant Ventures

Versant Ventures is a healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $2.3 billion under management and offices in Canada, the U.S., and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 65 Versant companies have achieved successful acquisitions or IPOs.

Versant Ventures, established in 1999 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed, Private Equity investments across Biotechnology, Life Science, Health Care, Biopharma, Therapeutics, Financial Services, Venture Capital, Finance, Cyber Security, Semiconductor. The organization boasts a portfolio of 375 investments, with an average round size of $40.0M and 105 successful exits. Their recent investments include Ambrx, Maverick Ventures, 5AM Ventures, M Ventures, Tavistock Life Sciences. The highest investment round they participated in was $1130.5B. Among their most notable exits are Ambrx and Maverick Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.